Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Primary objective of this study is to investigate the long-term tolerability and safety
profile of BIBF 1120 on top of pirfenidone treatment in patients with Idiopathic Pulmonary
Fibrosis who have completed a prior clinical trial of BIBF 1120 (1199.31).
Secondary objectives are to assess effects on some efficacy criteria during long term
treatment with BIBF 1120 on top of pirfenidone.